ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com



ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-07-04Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
ÍÆ¼ö²úÆ· :
ÍÆ¼öÐÂÎÅ
¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨

ʱ¼ä:2025-07-04    ×÷Õß: ¹ÜÀíÔ±

רÀûÃû³Æ£ºÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨
¼¼ÊõÁìÓò£º
±¾·¢Ã÷Éæ¼°Ï¸°û·Ö×ÓÉúÎïѧ¼¼ÊõÁìÓò£¬¾ßÌåÉæ¼°Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄ ÃâÒßÓ«¹â·½·¨£¬¸Ã·½·¨ÓÃÓÚϸ°ûÉúÎïѧ¡¢·Ö×ÓÉúÎïѧ¡¢ÃâÒßѧ¡¢Î¢ÉúÎïѧ¡¢²¡Àíѧ¼°ÁÙ´²¼ìÑé ÖжÔÍêÕûϸ°û(°üÀ¨Î¢ÉúÎï)Ä¿±ê¿¹Ô­µÄ¿ÉÊÓ»¯¼ì²â¡£
±³¾°¼¼Êõ£º
ÃâÒßÓ«¹â·ÖÎö·¨(Immunofluorescence assay, IFA)ÊÇϸ°û¡¢·Ö×ÓÉúÎïѧ³£ÓõÄÒ» ÖÖʵÑé·½·¨¡£°´ÕÕÑùÆ·ÌØÐÔ£¬ÃâÒßÓ«¹â·ÖÎö·¨·ÖΪ2´óÀàÒ»ÀàÓÃÓÚ±ê¼Ç¹Ì¶¨ÔÚ²£Æ¬(¸Ç ²£Æ¬»òÔØ²£Æ¬)ÉϵÄϸ°û(BhattacharyyaD£¬Hammond AT and Glick BS. High-quality immunofluorescence of cultured cells[J]. Methods Mol Biol, 2010,619 :403-410.)£» ÁíÒ»À༴ָÁ÷ʽϸ°ûÒÇÓ«¹â·ÖÎöϸ°ûÐüÒº(Cunningham RE. Indirect immunofluorescent labeling offixed cells [J]. Methods Mol Biol£¬2010£¬588 :335-339.)¡£Ç°ÕßµÄÖ÷ҪĿ µÄÊÇչʾϸ°û½á¹¹(ÀýÈ缡¶¯µ°°×Ë¿)¡¢°ûÄÚÄ¿±êµ°°×ÖʵĶ¨Î»¡¢Ï¸°û±íÃæ·Ö×Ó·Ö²¼µÈ (Bhattacharyya D£¬Hammond AT and Glick BS. High-quality immunofluorescence of cultured cells[J]. Methods Mol Biol£¬2010£¬619 :403-410. £»Lee AWiHertel LiLouie RK, et al¡¤ Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells[J]. J Immunol,2006£¬177 (6) :3960-3971.)¡£ ºóÕßµÄÖ÷ҪĿµÄÊÇ·Öѡϸ°û¡¢Í³¼ÆÏ¸°ûÖбêÖ¾ÐÔµ°°×µÄÑôÐÔÂÊ¡£ÓÃÓÚ¼ì²â²£Æ¬ÑùÆ·µÄÃâ ÒßÓ«¹â·ÖÎöÓÐ2ÖÖÖÆ±¸ÑùÆ·µÄ·½·¨(1)ʹϸ°ûÔÚÌØÖÆµÄ¸Ç²£Æ¬(¼´Ï¸°ûÅÀƬ)ÉÏÉú³¤£¬ ʹϸ°û×ÔÈ»Ìù¸½ÓÚ²£Æ¬ÉÏ£»(2)½«´ý¼ì²âµÄϸ°û(°üÀ¨¶¯/Ö²Îïϸ°ûºÍ΢ÉúÎïMTaber LH, Brasier F, Couch RB, et al. Diagnosis of herpes simplex virus infection by immunofluorescence[J]. J ClinMicrobiol,1976,3(3) :309-312. £»Didier ES, Orenstein JM,Aldras A,et al. Comparison of three staining methods for detecting microsporidia in fluids [J], J Clin Microbiol, 1995,33(12) :3138-3145.)ÐüÒºµÎµ½²£ ƬÉÏ£¬Ê¹Æä·ç¸É²¢Ìù¸½ÓÚ²£Æ¬ÉÏ¡£ÎÒÃǹ«¿ªµÄÊÇÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â ·½·¨£¬ÊôÓÚ·ÖÎöϸ°ûÅÀƬÑùÆ·(µÚÒ»Àà)µÄÃâÒßÓ«¹â·ÖÎö·½·¨¡£°´ÕÕ¿¹ÌåµÄʹÓã¬ÃâÒßÓ«¹â·ÖÎö·ÖΪ¼ä½ÓÃâÒßÓ«¹â·ÖÎöºÍÖ±½ÓÃâÒßÓ«¹â·ÖÎö2 ÖÖ¡£¼ä½ÓÃâÒßÓ«¹â·ÖÎö·½·¨Í¨¹ý¿¹Ô­ÌØÒìÐÔµÚÒ»¿¹Ìå(Ò»¿¹)±ê¼Ç¿¹Ô­£¬ÔÙÓÃÓ«¹â·Ö×Óñî ÁªµÄµÚ¶þ¿¹Ìå(¶þ¿¹)ÌØÒìÐÔ±ê¼ÇÒ»¿¹£¬´Ó¶øÊ¹¿¹Ô­ËùÔÚλµã·¢³öÓ«¹â¡£¶øÖ±½ÓÃâÒßÓ«¹â ·ÖÎöÊÇÓÃÓ«¹â·Ö×ÓñîÁªµÄ¿¹Ô­ÌØÒìÐԵĿ¹ÌåÖ±½Ó±ê¼Ç¿¹Ô­µÄ·½·¨¡£ÎÞÂÛÊǼä½ÓÃâÒßÓ«¹â·Ö Îö»¹ÊÇÖ±½ÓÃâÒßÓ«¹â·ÖÎö£¬ÎÒÃǹ«¿ªµÄÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨¾ùÊÊ Óá£ÓëͬÀàÐ͵ļ¸ÖÖÃâÒßÓ«¹â·ÖÎö·½·¨(Bhattacharyya D£¬Hammond AT and Glick BS. High-quality immunofluorescence of cultured cells[J]. Methods Mol Biol,2010, 619 :403-410. £»Taber LH, Brasier F£¬Couch RB, et al. Diagnosis of herpes simplex virus infection by immunofluorescence[J]. J Clin Microbiol£¬1976£¬3 (3) :309-312.£»Cunningham RE. Indirect immunofluorescent labeling of fixed cells[J]. Methods Mol Biol,2010,588 :335-339. £»Rosner K£¬ Mischke R and Schuberth HJ. Evaluation of a standard immunofluorescence assay and a new flow cytometric method for the detection of autoreactive antibodies in dogs with tumours[J]. Res Vet Sci£¬ 2007,82(1) :27-33. £»Inoue N£¬Mar EC£¬Dollard SC, et al. New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies[J]. Clin Diagn Lab Immunol£¬2000£¬7(3) :427-435. £»Thomp son TA and Wilkinson HW. Evaluation of a solid-phase immunofluorescence assay for detection of antibodies to Legionella pneumophila [J]. J Clin Microbiol£¬1982£¬16 (1) :202-204.)Ïà±È£¬ÎÒÃǹ«ŽÔµÄÒ»ÖÖ»ùÓÚϸ °ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨ÖÁÉÙ½ÚÊ¡40-70·ÖÖÓ(min)¡£ÎÒÃǹ«ŽÔµÄÕâÖÖз½·¨°ü À¨15min·â±Õ·õÓýºÍIOminµÄ¿¹Ìå(Ò»¿¹»ò¶þ¿¹)·õÓý£¬¶øÆäËü·½·¨ÐèÒª20-60min½øÐз⠱շõÓý(Bhattacharyya DiHammond AT and Glick BS. High-quality immunofluorescence of cultured cells[J]. Methods Mol Biol£¬2010£¬619 :403-410. £»Strang BL£¬Boulant S and Coen DM. Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44and is necessary for efficient viral replication [J]. J Virol£¬2010£¬84(4) :1771-1784. £»Thornton CR and Talbot NJ. Immunofluorescence microscopy and immunogold EM for investigating fungal infection of plants[J]. Nat Protoc£¬2006£¬1 (5) :2506-2511. £»Schneider Gasser EM,Straub CJ£¬Panzanelli P£¬et al. Immunofluorescence in brain sections -simultaneous detection of presynaptic and postsynaptic proteins in identified neurons [J]. Nat Protoc,2006£¬1 (4) 1887-1897.)ÒÔ¼°0. 5-3 Сʱ(h)ÓÃÓÚ¿¹Ìå(Ò»¿¹»ò¶þ¿¹)·õÓý(Bhattacharyya DiHammond AT and Glick B S. High-quality immunofluorescence of cultured cells[J]. Methods Mol Biol£¬2010£¬619 :403-410. £»Thornton CR and Talbot NJ. Immunofluorescence microscopy and immunogold EM for investigating fungal infection of plants[J]. Nat Protoc,2006,1 (5) :2506-2511. £»Schneider Gasser EM, Straub CJ, Panzanelli P£¬et al. Immunofluorescence in brain sections :simultaneous detection of presynaptic and postsynaptic proteins in identified neurons[J]. Nat Protoc, 2006£¬1(4) :1887-1897. £»Rogers SL and Rogers GC. Culture of Drosophila S2cells and their use for RNAi¡ªmediated lossÒ»ofÒ»function studies and immunofluorescence microscopy [J]. Nat Protoc, 2008, 3 (4) :606-611.)¡£´ËÍ⣬ÎÒÃÇáŠÓõÄËÙЧƯϴ·½·¨ÄÜ¿ì ËÙ(ÿ´ÎƯϴһƬÅÀƬÐèʱ²»µ½lmin)ÓÐЧµØÆ¯Ï´µôϸ°ûÅÀƬÉϵķ´Ó¦ÈÜÒººÍδ½áºÏµÄ¿¹ Ì壬ËùÐèʱ¼ä±ÈͬÀà·½·¨¸ü¶Ì(Bhattacharyya DiHammond AT and Glick BS. High-quality immunofluorescence of cultured cells[J]. Methods Mol Biol,2010,619 :403-410.£» Taber LH£¬Brasier F£¬Couch RB,et al. Diagnosis of herpes simplex virus infection by immunofluorescence[J]. J Clin Microbiol£¬1976£¬3(3) :309-312. £»Rosner KiMischke R and Schuberth HJ. Evaluation of a standard immunofluorescence assay and a new flow cytometric method for the detection of autoreactive antibodies in dogs with tumours[J]. Res Vet Sci£¬2007£¬82 (1) :27-33. £»Thompson TA and Wilkinson HW. Evaluation of a solid-phase immunofluorescence assay for detection ofantibodies to Legionella pneumophila[J]. J Clin Microbiol,1982,16(1) :202-204.)¡£ ÁíÒ»·½Ã棬ÎÒÃǵķ½·¨¶Ô¿¹ÌåÈÜÒºµÄÐèÇóΪ25 ¦Ì l/254mm2 (°´ÕÕ¦µ 18mm¹æ¸ñµÄÅÀƬ¼ÆËã)£» ¶ø°´ÕÕ´«Í³·½·¨¿¹ÌåÈÜÒºµÄÓÃÁ¿Ô¼Îª150 ¦Ì l/22mm2 (Rogers SL and Rogers GC. Culture of Drosophila S2cells and their use for RNAi¡ªmediated loss-of-function studies and immunofluorescence microscopy [J]. Nat Protoc£¬2008£¬3 (4) :606-611.)¡£¾­¼ìË÷δ ·¢ÏÖÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨±»¹«¿ª»òʹÓá£

·¢Ã÷ÄÚÈÝ
±¾·¢Ã÷µÄÄ¿µÄÊÇÔÚÓÚÌṩÁËÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬¸Ã·½ ·¨ÔÚ±£³Ö±ê¼Çϸ°ûµÄÃâÒßÓ«¹âÖÊÁ¿(°üÀ¨¿¹Ô­Ê¶±ðÁéÃô¶È¡¢×¼È·ÐÔ¡¢Ó«¹âͼÏñÇåÎú¶ÈµÈ)²» ϽµµÄǰÌåÏ£¬Ã÷ÏÔËõ¶ÌÃâÒßÓ«¹âȾɫ²Ù×÷µÄʱ¼ä£¬²¢Ã÷ÏÔÏ÷¼õÁËÒ»¿¹ºÍ¶þ¿¹µÄʹÓÃÁ¿£¬Ëù Ð迹ÌåµÄÌå»ýԼΪ´«Í³·½·¨ÐèÒªÁ¿µÄ1. 5%£¬´Ó¶ø´ïµ½¿ìËÙ¡¢¾­¼Ã֮ĿµÄ¡£ÎªÁË´ïµ½ÉÏÊöÄ¿µÄ£¬±¾·¢Ã÷²ÉÈ¡ÒÔϼ¼Êõ´ëÊ©¡ªÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬Æä²½ÖèÊÇA¡¢Ï¸°ûÅàÑø²¢¹Ì¶¨ÓڸDz£Æ¬ÉÏ£¬ÖƱ¸Ï¸°ûÅÀƬ(¼´¿ÉÒÔÌù¸½Ï¸°ûµÄÔ²ÐθDz£Æ¬)£¬ ʹÃâÒßÓ«¹âȾɫ²Ù×÷¸ü¼Ó·½±ã¡£ËùÊöµÄϸ°ûÅÀƬÑùÆ·µÄÖÆ±¸¹ý³ÌÊÇ1)ϸ°ûÅÀƬÑùÆ·µÄÖÆ±¸¹ý³Ìa ÔÚ½ÓÖÖϸ°ûǰ£¬ÏȽ«Ãð¾úºóµÄÅÀƬ(coverslip)·ÅÈëÅàÑøÃó£¬ÔÙ¼ÓÈëÅàÑø»ùºÍ ϸ°û£¬Ê¹Ï¸°û¾ù„òµØÌù¸½ÔÚÅÀƬÉϱíÃæºÍδ±»ÅÀƬ¸²¸ÇµÄÅàÑøÃóµ×²¿¡£´ýϸ°ûÌù±Úºó°´¸÷ ×ÔµÄʵÑ鼯»®ÅàÑøºÍ´¦Àíϸ°û¡£ÔÚϸ°ûÌù¸½¼°Éú³¤¹ý³ÌÖо¡Á¿²»ÒªÊ¹ÅÀƬÏà»¥ÖØµþ¡£±¾·¨ ÊÊÓÃÓÚËùÓÐÌù±Úϸ°û£¬ËùÓõÄÅàÑø»ùËæÏ¸°ûÅàÑøÌØÐÔ¶ø±ä»¯£¬ÊµÊ©ÀýÖÐËùÓÃϸ°ûΪ³ÉÏËά ϸ°û£¬ÅàÑø»ùΪMEM¡£b ½«º¬Óдý¼ì²âϸ°ûµÄÐüÒºµÎ¼ÓÔÚÅÀƬÉÏ£¬Ê¹Æä·ç¸É¡£2)ÊÕ¼¯Ï¸°ûÅÀƬÓÃÄ÷×Ó½«Ï¸°ûÅàÑøÃóÖеÄÅÀƬÑùÆ·È¡³ö£¬·ÅÈë12¿×°åÖÐ(Ô¤ÏÈ ÔÚÿ¸ö¿×ÖÐ×¢ÈëUml PBS)£¬ÅÀƬÕýÃæ(Ìù¸½Ï¸°ûµÄÒ»Ãæ)ÏòÉÏ¡£3)ƯϴÎü³ý12¿×°åÖеÄPBS£¬ÔٴμÓÈëPBS²¢Îü³ý¡£4)ϸ°û¹Ì¶¨Ïòÿ¸ö¿×¼ÓÈëIml¹Ì¶¨¼Á3% (M/V)¼×È©ÈÜÒº»òÆäËû¹Ì¶¨¼Á£¬Èç¶à¾Û ¼×È©¡¢¼×´¼¡¢Îì¶þÈ©¡¢±ûͪµÈ£¬ÊÒÎÂO0-25¡ãC£¬ÒÔÏÂÏàͬ)·ÅÖÃlOmin¡£ËùÊöµÄ¹Ì¶¨¼ÁΪ¼×È©¡¢ ¶à¾Û¼×È©¡¢¼×´¼¡¢Îì¶þÈ©¡¢±ûͪµÈÈÜÒºÖеÄÈÎÒâÒ»ÖÖ¡£5)ƯϴÎü³ý¹Ì¶¨¼Á£¬ÓÃPBSÏ´2´Î¡£ËùÊöµÄ¹Ì¶¨¼ÁΪ¼×È©¡¢¶à¾Û¼×È©¡¢¼×´¼¡¢Îì¶þ È©¡¢±ûͪµÈÈÜÒºµÄÈÎÒâÒ»ÖÖ¡£6)ϸ°û´©Í¸Ã¿¿×¼ÓÈëIml´©Í¸¼Á(1% Triton-X-100£¬ÆäËûЧ¹û½ÏºÃµÄ´©Í¸¼Á»¹ °üÀ¨NP-40¡¢Ôí½ÇÜÕ¡¢ÍÁΡ¢Ñ󵨻ÆÔíÜÕµÈ)£¬ÊÒηÅÖÃ5-lOmin¡£ËùÊöµÄ´©Í¸¼ÁΪNP-40¡¢Ôí ½ÇÜÕ¡¢ÍÁΡ¢Ñ󵨻ÆÔíÜÕµÈÖеÄÈÎÒâÒ»ÖÖ¡£7)ƯϴÎü³ý´©Í¸¼Á£¬ÓÃPBSÏ´1´Î¡£B.ÃâÒßÓ«¹âȾɫ1)Ô¤±¸·â¿ÚĤºÍPBS¡£2)·â±ÕÅäÖÆ(½«30 ¦Ì 1̥ţѪÇåÓë70 ¦Ì 1Ô¤ÏÈÅäºÃµÄÎÞѪÇå·â±ÕÒº»ìºÏ£¬ÎÞѪÇå ·â±ÕÒºÅäÖÆ¼û¡°B.ÊÔ¼Á ÎÞѪÇå·â±ÕÒº¡±)²¢µã¼Ó·â±ÕÒº£»ÅÀƬµÄƯϴÓëÕã¸É(ÓÃÄ÷×Ó¼ÐסÅÀƬ£¬¿ìËÙ¡¢·´¸´15-35´ÎµØÊ¹ÅÀƬ½þ/³öPBS½øÐÐÆ¯Ï´£¬ÒÀ´ÎÔÚ3¸öÁ¿±­ÖнøÐÐÆ¯Ï´£»È»ºó °ÑÅÀƬµÄÒ»±ß·ÅÖ½½íÉÏÎüÈ¥¶àÓàPBS)£»ÅÀƬ(ÕýÃæÏòÏÂ)¸ÇÓÚ·â±ÕÒºÉÏ£¬ÊÒηõÓý15min; ÖÕÖ¹·â±Õ(ÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬Ê¹ÅÀƬ¸¡Æð)£»ËÙЧƯϴÓëÕã¸É¡£3) Ò»¿¹·õÓýÅäÖÆÒ»¿¹ÈÜÒº(Ò»¿¹Ô­ÒºÓÃÎÞѪÇå·â±ÕҺϡÊÍ£¬Ï¡ÊͱÈÀýÒòËùʹÓà µÄ¿¹Ìå¶øÒ죬²¢²Î¼û¡°B.ÊÔ¼Á ¿¹Ì塱²¿·Ö)£»ÅÀƬ(ÕýÃæÏòÏÂ)¸ÇÓÚÒ»¿¹ÈÜÒºÉÏ£¬ÊÒηõÓý IOmin £»ÖÕÖ¹Ò»¿¹·õÓý(ÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬Ê¹ÅÀƬ¸¡Æð)£»ËÙЧƯ Ï´ÓëÕã¸É(ÓÃÄ÷×Ó¼ÐסÅÀƬ£¬¿ìËÙ¡¢·´¸´15-35´ÎµØÊ¹ÅÀƬ³ö/ÈëPBS½øÐÐÆ¯Ï´£¬ÒÀ´ÎÔÚ3 ¸öÁ¿±­ÖнøÐÐÆ¯Ï´£»È»ºó°ÑÅÀƬµÄÒ»±ß·ÅÖ½½íÉÏÎüÈ¥¶àÓàPBS)¡£4) ¶þ¿¹·õÓýÅäÖÆ¶þ¿¹ÈÜÒº(¶þ¿¹Ô­Òº¼°Ï¸°ûºËȾÁÏÓÃÎÞѪÇå·â±ÕҺϡÊÍ£¬Ï¡ÊÍ ±ÈÀýÒòËùʹÓõĿ¹Ìå¶øÒ죬²¢²Î¼û¡°B.ÊÔ¼Á ¿¹Ì塱²¿·Ö)£»ÅÀƬ(ÕýÃæÏòÏÂ)¸ÇÓÚ¶þ¿¹ÈÜ ÒºÉÏ£¬ÊÒηõÓýIOmin £»ÖÕÖ¹¶þ¿¹·õÓý(ÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬Ê¹ÅÀƬ ¸¡Æð)£»ËÙЧƯϴÓëÕã¸É(ÓÃÄ÷×Ó¼ÐסÅÀƬ£¬¿ìËÙ¡¢·´¸´15-35´ÎµØÊ¹ÅÀƬ³ö/ÈëPBS½øÐРƯϴ£¬ÒÀ´ÎÔÚ3¸öÁ¿±­ÖнøÐÐÆ¯Ï´£»È»ºó°ÑÅÀƬµÄÒ»±ß·ÅÖ½½íÉÏÎüÈ¥¶àÓàPBS)¡£5)×°ÔØÅÀƬ׼±¸ÅÀƬ£»µã¼Ó¿¹Ó«¹âË¥Í˼Á(º¬¿¹Ó«¹âË¥Í˼ÁÅä·½)£»Çå½àÅÀƬ£» ½«ÅÀƬ¸ÇÓÚÔØ²£Æ¬ÉϵĿ¹Ó«¹âË¥Í˼ÁÉÏ(ÕýÃæÏòÏÂ)£¬ÓÃÄ÷×ÓÇáѹÅÀƬÒÔ¾¡Á¿Ìù½ôÔØ²£Æ¬£» ÓÃÎü³ýÅÀƬÖÜΧ¶àÓàµÄ¿¹Ó«¹âË¥Í˼Á£»ÔÚÅÀƬ±ßÔµµãÉÏ2-3µÎÖ¸¼×ÓÍÒÔ¸¨Öú¹Ì¶¨£»¹Û²ì»ò ±£´æÑùÆ·¡£ËùÊöµÄ¿¹Ó«¹âË¥Í˼ÁÅ䷽ΪIOmg¶Ô±½¶þ°·ÈܽâÈëIml PBS£¬ÔÙÓë9ml¸ÊÓÍ»ìºÏ£¬ ÅäÖÆ³Éº¬lmg/ml¶Ô±½¶þ°·ºÍ90% (V/V)¸ÊÓ͵ÄÈÜÒº¡£C.Ó«¹âÏÔ΢¾µÏ¹۲ìÓ«¹â¼°ÅÄÕÕ¡£Ó«¹â¼¤·¢¹â¾­ÏàÓ¦µÄÓ«¹âÂË¹âÆ¬ºó¿´µ½Ä¿µÄ·Ö ×ÓÏÔʾÇåÎú¡¢ÌØÒìµÄºìÉ«¡¢ÂÌÉ«¡¢À¶É«Ó«¹â¡£Ó«¹âȾɫµÄ°Ð·Ö×ÓÌØÒìÓ«¹âÇ¿£¬¶øÇÒȾɫ²»Í¬µÄ °Ð·Ö×Ó(UL44Óëϸ°ûºË£¬IE-l¡¢aCtinÓëϸ°ûºË)µÄÓ«¹âÎÞÃ÷ÏÔÏ໥¸ÉÈÅÏÖÏ󣬽ṹ¡¢Í¼ÏñÇå Îú£¬¶¨Î»×¼È·¡£(¾ßÌå½á¹û¼ûͼ1¡¢Í¼2£¬ÒÔ¼°¡°ÊµÑé½á¹û˵Ã÷¡±)±¾·¢Ã÷ÓëÏÖÓм¼ÊõÏà±È£¬¾ßÓÐÏÂÁÐÓŵã1)ʹÓÃϸ°ûÅÀƬ(ÑùÆ·)¸²¸ÇÊÔ¼ÁµÄ·½Ê½½øÐзâ±Õ¡¢Ò»¿¹¡¢¶þ¿¹µÄ·õÓý£¬½áºÏ¶ÀÌØ µÄϸ°ûÅÀƬƯϴ·½·¨£¬´ïµ½Ê¡Ê±¼ä¡¢Ê¡¹óÖØÊÔ¼Á(Ò»¿¹¡¢¶þ¿¹)µÄЧ¹û(Thornton CR and Talbot NJ. Immunofluorescence microscopy and immunogold EM for investigating fungal infection of plants[J]. Nat Protoc,2006,1 (5) :2506-2511. £»Rogers SL and Rogers GC. Culture of Drosophila S2 cells and their use for RNAi-mediated loss¡ªof¡ªfunction studies and immunofluorescence microscopy[J]. Nat Protoc,2008, 3(4) :606-611.)¡£2)ÖÊÁ¿/Ч¹ûºÃ¡£ÄÜ׼ȷµØ¶¨Î»¿¹Ô­µÄλÖúÍÏÔʾÏà¶ÔÁ¿£¬Ëù±ê¼Ç°Ð·Ö×ÓµÄÓ«¹â ÇåÎú¶ø±³¾°Ó«¹âºÜµÍ¡£3)¼ò±ãÒ×ÐС£²Ù×÷¼ò±ã£¬ÈÝÒ×ÕÆÎÕ£»³ýÑùÆ·¡¢ÊÔ¼ÁµÄ±£²ØÒÔÍ⣬ËùÓвÙ×÷ÔÚÊÒÎÂÏ ½øÐС£


ͼIAÈ˾Þϸ°û²¡¶¾(AD169)ͼIBÈ˾Þϸ°û²¡¶¾(AD169)ͼICÈ˾Þϸ°û²¡¶¾(AD169)¸ÐȾºó24hϸ°ûºËÄÚÐγɵĵã×´¸´ÖÆÖÐÐÄ¡£ ¸ÐȾºó4 ϸ°ûºËÄÚÐγɵÄСÐ͸´ÖÆÖÐÐÄ¡£ ¸ÐȾºó60hϸ°ûºËÄÚÐγɵÄÖÐÐ͸´ÖÆÖÐÐÄ¡£
ͼIDÈ˾Þϸ°û²¡¶¾(AD169)¸ÐȾºóϸ°ûºËÄÚÐγɵĵ¥¸ö¾Þ´ó¸´ÖÆÖÐÐÄ¡£Í¼IEͼIAµÄϸ°ûºË¡£Í¼IFͼIBµÄϸ°ûºË¡£Í¼IGͼICµÄϸ°ûºË¡£Í¼IHͼIDµÄϸ°ûºË¡£Í¼1ÖÐÈ˾Þϸ°û²¡¶¾(AD169Öê)¸ÐȾ³ÉÏËάϸ°ûºó²¡¶¾¸´ÖÆÖÐÐĵÄÐγÉÓë·¢Õ¹¡£ A¡¢B¡¢C¡¢Dºìɫӫ¹â·Ö±ðΪÈ˾Þϸ°û²¡¶¾(AD169Öê)¸ÐȾºó24h¡¢48h¡¢60h¡¢96h¸´ÖÆÖÐÐÄ¡£ E¡¢F¡¢G¡¢HÀ¶É«Ó«¹âÏÔʾÏàÓ¦µÄA¡¢B¡¢C¡¢DµÄϸ°ûºË¡£Í¼Öбê³ß=10 ¦Ì m¡£Í¼2AÒõÐÔ¶ÔÕÕϸ°ûºË¡£Í¼2BÒõÐÔ¶ÔÕÕϸ°û¹Ç¼Ü(actin)¡£Í¼2CÒõÐÔ¶ÔÕÕϸ°ûÖÐÈ˾Þϸ°û²¡¶¾IE-Iµ°°×ΪÒõÐÔ¡£Í¼2DÈ˾Þϸ°û²¡¶¾¸ÐȾϸ°ûºË¡£Í¼2EÈ˾Þϸ°û²¡¶¾¸ÐȾºó12hϸ°û¹Ç¼Ü(actin)±ä»¯¡£Í¼2FÈ˾Þϸ°û²¡¶¾¸ÐȾºó12hϸ°ûºËÖÐIE-Iµ°°×ÑôÐÔ¡£Í¼2ÖÐΪÈ˾Þϸ°û²¡¶¾(TowneÖê)¸ÐȾ³ÉÏËάϸ°ûºó(12h)ϸ°û¹Ç¼ÜµÄ±ä»¯¡£À¶ ɫӫ¹âÏÔʾϸ°ûºË£¬ÂÌɫӫ¹âÏÔʾϸ°ûµÄ¼¡¶¯µ°°×(actin)£¬ºìɫӫ¹â±ê¼ÇµÄÊÇÈ˾Þϸ°û²¡ ¶¾IE-Iµ°°×¡£Í¼Öбê³ß=20 ¦Ì m¡£
¾ßÌåʵʩÀý·½Ê½ÏÂÃæ½áºÏ¸½Í¼¶Ô±¾·¢Ã÷½øÒ»²½²ûÊö¡ªÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬Æä²½ÖèÊÇI¡¢Ï¸°ûÅÀƬÑùÆ·µÄÖÆ±¸I. 1ϸ°ûÌù¸½·½·¨A ÔÚ½ÓÖÖϸ°û(Ìù±Úϸ°û)ǰ£¬ÏȽ«Ãð¾úºóµÄ¸Ç²£Æ¬(coverslip)·ÅÈëÅàÑø Ãó£¬ÔÙ¼ÓÈëMEMÅàÑø»ùºÍ³ÉÏËάϸ°û(ÊÊÓÃÓÚ¸÷ÖÖÌù±Úϸ°û£¬ÅàÑøÊ±¸ù¾Ýϸ°ûÒªÇóʹÓÃÏàÓ¦ µÄÅàÑø»ù)£¬Ê¹Ï¸°û¾ù„òµØÌùÓڸDz£Æ¬±íÃæ(»ñµÃÅÀƬ)ºÍδ±»¸Ç²£Æ¬¸²¸ÇµÄÅàÑøÃó¡£´ý ϸ°ûÌù±Úºó£¬ÒÔ¸ÐȾ¸´ÊýΪ5(MI0 = 5)µÄ²¡¶¾Á¿¸ÐȾ£¬¶ÔÕÕ×é²»½ÓÖÖ²¡¶¾(ÓõÈÌå»ýµÄÌõ ¼þÅàÑø»ùÌæ´ú)£¬¸ù¾ÝÑо¿Ä¿µÄÖ®ÒªÇóÔÚÖ¸¶¨µÄʱ¼äµãÊÕ¼¯ÅÀƬ(¾ßÌåʱ¼ä¼û¡°ÊµÑé½á¹û˵ Ã÷¡±²¿·Ö)¡£ÔÚϸ°ûÌù¸½¼°ÅàÑø¹ý³ÌÖо¡Á¿±ÜÃâÅÀƬÏà»¥ÖØµþ¡£·½·¨B ½«º¬ÓÐÌØ¶¨Å¨¶È(5 X 105/ml 5 X 106/ml)µÄ´ý¼ìϸ°ûµÄϸ°ûÐüÒºµÎ¼ÓÔÚ ¸Ç²£Æ¬ÉÏ£¬Ê¹Æä·ç¸É¡£´Ë·¨ÊÊÓÃÓÚÐü¸¡Ï¸°û¡¢ÒÈøÏû»¯µÄÌù±Úϸ°û¡¢Î¢ÉúÎïµÈ¡£I. 2ÊÕ¼¯Ï¸°ûÅÀƬ¸ù¾ÝÑо¿ÒªÇóÔÚËùÐèʱ¼äµã£¬ÓÃÎÞ¾úÄ÷×Ó´Óϸ°ûÅàÑøÃóÖÐ È¡³öÅÀƬÑùÆ·£¬·ÅÈë12¿×°åÖÐ(Ô¤ÏÈÔÚÿ¸ö¿×ÖÐ×¢Èëaiil PBS)£¬ÅÀƬµÄÕýÃæ(¼´Ï¸°û Ìù¸½µÄÒ»Ãæ)±ØÐëÏòÉÏ¡£ËùÓÃϸ°ûÅÀƬÊÇÄܹ»Ê¹Ï¸°û½ÏÀιÌÌù¸½ÓÚÆäÉϵĸDz£Æ¬£¬ºñ¶È 0. 15-0. 22mm£¬Ê×ѡԲÐÎÇÒÖ±¾¶Îª1. 5-2. 2cm£¬·½ÐÎÒà¿ÉʹÓÃÇÒ³¤¶ÈΪ1. 5-2. 2cm¡£I. 3³ýÈ¥Ñù±¾±íÃæµÄÅàÑøÒºÎü³ý12¿×°åÖеÄPBS £»ÔٴμÓÈëPBS²¢Îü³ýÒÔÏ´È¥Ñù ±¾±íÃæµÄÅàÑøÒº¡£I. 4ϸ°û¹Ì¶¨Ã¿¿×¼ÓÈëIml¹Ì¶¨¼Á(3% V/V¼×È©ÈÜÒº)£¬ÊÒÎÂ(20_25¡ãCÒÔÏÂÏà ͬ)¹Ì¶¨lOmin¡£ÆäËû¹Ì¶¨¼Á£¬ËùÊöµÄ¹Ì¶¨¼ÁΪ¶à¾Û¼×È©¡¢¼×´¼¡¢Îì¶þÈ©¡¢±ûͪµÈÈÎÒâÒ»ÖÖ¡£
I. 5ƯϴÎü³ý¼×È©ÈÜÒº£¬¼ÓÈëPBSÔÙÎü³ý£¬Èç´Ë²Ù×÷2´ÎÒÔÏ´È¥²ÐÁôµÄ¼×È©¡£(ÖÁ ´Ë£¬¿ÉÒÔ¼ÌÐøÏÂÃæµÄʵÑ飻Ҳ¿ÉÒÔ½«ÅÀƬ±£´æÔÚÊÊÁ¿PBSÖУ¬´¢´æÓÚ4¡ãCÌõ¼þÏ£¬±£ÖÊÆÚ3¸ö Ô£¬µ«ÇÐÎðÈÃPBS¸Éµô¡£)I. 6ϸ°û´©Í¸Ã¿¿×¼ÓÈëIml´©Í¸¼Á(1 % Triton-X-100)£¬ÊÒηÅÖÃ5-lOmin¡£Ëù ÊöµÄ´©Í¸¼ÁΪNP-40¡¢Ôí½ÇÜÕ¡¢ÍÁΡ¢Ñ󵨻ÆÔíÜÕµÈÈÎÒâÒ»ÖÖ¡£I. 7ƯϴÎü³ý´©Í¸¼Á£¬¼ÓPBSƯϴ1´Î¡£(ÖÁ´Ë£¬¿ÉÒÔ¼ÌÐøÏÂÃæµÄʵÑ飻Ҳ¿ÉÒÔ¼Ó PBSºó·Å4¡ãC±ùÏäÖдæ·Å£¬±£ÖÊÆÚ3¸öÔ£¬µ«ÇÐÎðÈÃPBS¸Éµô¡£)ËùÊöµÄ´©Í¸¼ÁΪNP-40¡¢Ôí ½ÇÜÕ¡¢ÍÁΡ¢Ñ󵨻ÆÔíÜÕµÈÈÎÒâÒ»ÖÖ¡£IIÃâÒßÓ«¹âȾɫII. 1×¼±¸È¾É«ÔÚʵÑę́Éϵμ¸µÎË®£¬¼ôÒ»ÕÅÊʵ±³¤¶È(¸ù¾ÝÅÀƬÊý¾ö¶¨Ä¤µÄ³¤ ¶È)µÄparaf ilmĤÌùÔÚÌ¨ÃæÉÏ£¬ÓüǺűÊÔÚparaf ilmĤÉÏ»®·ÖÇøÓò£»·ÅÖÃ3¸öÊ¢ÂúPBSµÄ IOOmlËÜÁÏÁ¿±­£¬È¡³ö´æ·ÅÅÀƬµÄ12¿×°å¡£II. 2 ·â±Õ:II. 2. 1ÅäÖÆ·â±ÕÒºÒÔÎÞѪÇå·â±ÕÒº(¼û¡°B.ÊÔ¼Á¡¤ÎÞѪÇå·â±ÕÒº¡±)Ϊ»ù´¡Åä ÖÆº¬30% (V/V)̥ţѪÇåµÄ·â±ÕÒº(½«30 ¦Ì 1̥ţѪÇåÓë70 ¦Ì 1Ô¤ÏÈÅäºÃµÄÎÞѪÇå·â±ÕÒº »ìºÏ)£¬ÔÚÿ¸öÔ¤¶¨µÄÑùÆ·ÇøÓòÄÚ¼ÓÈë30 ¦Ì 1¸Ã·â±ÕÒº¡£II. 2. 2ƯϴÓëÕã¸ÉÓÃÄ÷×ÓÈ¡³öÅÀƬ£¬°Ñ³ÖÅÀƬ½þÓÚPBSÖÐÉÔÉÔÆ¯Ï´£¬Ï´ºóÈÃÅÀƬ Ò»±ßµÄ±ßÔµ½Ó´¥Ö½½í£¬ÎüÈ¥ÅÀƬÉϵÄPBS¡£II. 2. 3·â±Õ½«ÅÀƬ¸ÇÔÚÔ¤ÏȵãÓÚparaf ilmĤÉϵĺ¬30% (V/V)̥ţѪÇåµÄ·â ±ÕÒºÉÏ(ÕýÃæ³¯ÏÂ)£¬ÊÒÎÂÏ·õÓý15min¡£II. 2. 4ÖÕÖ¹·â±ÕÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬Ê¹ÅÀƬ¸¡Æð¡£II. 2. 5ËÙЧƯϴÓëÕã¸ÉÓÃÄ÷×ӰѳÖÅÀƬ£¬¿ìËÙ¡¢ÉÏÏ·´¸´µØÊ¹ÅÀƬ½þ/³öPBS¶à ´Î(10´Î)½øÐÐÆ¯Ï´¡£Ï´ºóÈÃÅÀƬһ±ßµÄ±ßÔµ½Ó´¥Ö½½í£¬ÎüÈ¥ÅÀƬÉϵÄPBS¡£II. 3 ¡ª¿¹·õÓýII. 3. 1ÅäÖÆÒ»¿¹ÔÚ·â±Õ·õÓýÆÚ¼ä£¬ÓÃÎÞѪÇå·â±ÕҺϡÊÍÒ»¿¹(Ï¡ÊͱÈÀý¼û ¡°B.ÊÔ¼Á¡¤¿¹Ì塱)£»ÔÚ·â±Õ·õÓý¼´½«½áÊøÊ±£¬ÔÚÿ¸öÔ¤¶¨Î»µã¼ÓÉÏ25 ¦Ì 1 ¡ª¿¹ÈÜÒº¡£II. 3. 2 Ò»¿¹·õÓý½«²½ÖèII. 2. 5Ï´ºÃÕã¸ÉµÄÅÀƬ¸ÇÔÚÔ¤ÏȵãÓÚparaf ilmĤÉ쵀 25 ¦Ì 1 Ò»¿¹ÈÜÒºÉÏ(ÕýÃæ³¯ÏÂ)£¬ÊÒÎÂÏ·õÓýlOmin¡£II. 3. 3ÖÕÖ¹Ò»¿¹·õÓýÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬Ê¹ÅÀƬ¸¡Æð¡£II. 3. 4ËÙЧƯϴÓëÕã¸ÉÓÃÄ÷×ӰѳÖÅÀƬ£¬¿ìËÙ¡¢ÉÏÏ·´¸´µØÊ¹ÅÀƬ½þ/³öPBS¶à ´Î(30´Î)½øÐÐÆ¯Ï´¡£Ï´ºóÈÃÅÀƬһ±ßµÄ±ßÔµ½Ó´¥Ö½½í£¬ÎüÈ¥ÅÀƬÉϵÄPBS¡£II. 4 ¶þ¿¹·õÓýII. 4. 1ÅäÖÆ¶þ¿¹ÈÜÒºÔÚÒ»¿¹·õÓýÆÚ¼ä£¬½«¶þ¿¹¼°Ï¸°ûºËȾÁÏÔÚͬһ·ÝÎÞѪÇå·â ±ÕÒºÀïÏ¡ÊÍ»ì„ò(¾ßÌåµÄÏ¡ÊͱÈÀý¼û¡°B.ÊÔ¼Á ¿¹Ì塱)£»ÔÚÒ»¿¹·õÓý¼´½«½áÊøÊ±£¬ÔÚÿ¸ö Ô¤¶¨Î»µã¼ÓÉÏ25 ¦Ì 1¸ÃÈÜÒº¡£II. 4. 2 ¶þ¿¹·õÓý½«²½ÖèII. 3. 4Ï´ºÃÕã¸ÉµÄÅÀƬ¸ÇÔÚÔ¤ÏȵãÓÚparaf ilmĤÉ쵀 25 ¦Ì 1 ¶þ¿¹ÈÜÒºÉÏ(ÕýÃæ³¯ÏÂ)£¬ÊÒÎÂÏ·õÓýlOmin¡£II. 4. 3ÖÕÖ¹¶þ¿¹·õÓýÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬Ê¹ÅÀƬ¸¡Æð¡£II. 4. 4ËÙЧƯϴÓëÕã¸ÉÓÃÄ÷×ӰѳÖÅÀƬ£¬¿ìËÙ¡¢ÉÏÏ·´¸´µØÊ¹ÅÀƬ½þ/³öPBS¶à´Î(30´Î)½øÐÐÆ¯Ï´¡£Ï´ºóÈÃÅÀƬһ±ßµÄ±ßÔµ½Ó´¥Ö½½í£¬ÎüÈ¥ÅÀƬÉϵÄPBS¡£ËùÊöµÄ²½ÖèII. 2¡¢11.3¡¢II. 4ÖÐËÙЧƯϴ¾ßÌå·½·¨ÊÇ£¬ÓÃÄ÷×ӰѳÖÅÀƬ£¬¿ìËÙ¡¢ÉÏ Ï·´¸´µØÊ¹ÅÀƬ½þ/³öPBS¶à´Î(15-35´Î)£¬ÒÀ´ÎÔÚ3¸öÁ¿±­ÖнøÐÐÆ¯Ï´¡£Ï´ºóÈÃÅÀƬһ ±ßµÄ±ßÔµ½Ó´¥Ö½½í£¬ÎüÈ¥ÅÀƬÉϵÄPBS¡£II. 5×°ÔØÅÀƬII. 5. 1×¼±¸Ôز£Æ¬ÔÚ¶þ¿¹·õÓýÆÚ¼ä£¬×¼±¸¸É¾»µÄÔØ²£Æ¬(Èç¹û²»¹»¸É¾»ÓÃ70% (V/V)¾Æ¾«²ÁÏ´¸É¾»)£¬ÓüǺűʱê×¢±ØÒªµÄÐÅÏ¢¡£II. 5. 2×¼±¸¿¹Ó«¹âË¥Í˼ÁÔÚ¶þ¿¹·õÓýÆÚ¼ä£¬´Ó-20¡ãC±ùÏäÖÐÈ¡³ö¡¢ÈÚ»¯¿¹Ó«¹âË¥ Í˼Á£¬ÔÚÔØ²£Æ¬ÉϼÓÉÏÒ»µÎÈÜÒº(ÿ¸öÔØ²£Æ¬ÄÜ·Å3¸öÅÀƬ£¬Ã¿¸öÅÀƬÐèÒªÒ»µÎ¿¹Ó«¹âË¥ÍË ¼Á)¡£¿¹Ó«¹âË¥Í˼Á³ý¶Ô±½¶þ°·Í⣬»¹¿ÉÓæ©-4-DiazabicycloQ£¬2£¬2)-octane (DABCO)»ò ¦Ç-propyl gallate (NPG)¡£II. 5. 3Çå½àÅÀƬÓÃKimwipesÖ½½í²ÁÊò½ÖèII. 4. 4Ï´ºÃÕã¸ÉÅÀƬµÄ±³Ãæ¡£II. 5. 4×°ÔØÅÀƬ½«ÅÀƬ¸ÇÓÚÔØ²£Æ¬ÉϵĿ¹Ó«¹âË¥Í˼ÁÉÏ(ÕýÃæÏòÏÂ)£¬ÓÃÄ÷×Ó ÇáѹÅÀƬʹÆäÌù½ôÔØ²£Æ¬£»ÓÃÁ¬½Óµç¶¯ÎüÒýÆ÷µÄ°Í˹µÂ¹ÜÎü³ýÅÀƬÖÜΧ¶àÓàµÄ¿¹Ó«¹âË¥ÍË ¼Á£»ÔÚÅÀƬ±ßԵͿÉÙÐíÖ¸¼×ÓÍÒÔ¸¨Öú¹Ì¶¨¡£II. 5. 5¹Û²ì»ò´¢´æÈ¾ºÃµÄÑù±¾ÖƱ¸ºÃµÄÑùÆ·¿ÉÒÔÖ±½ÓÔÚÓ«¹âÏÔ΢¾µÏ¹۲죬Ҳ ¿ÉÒÔ4¡ãC±Ü¹â±£´æ1ÖÜ¡£IIIÏÔ΢¾µ¹Û²ì¼°ÅÄÕÕʹÓÃÓ«¹âÏÔ΢¾µ¿ÉÒÔ¹Û²ìÑùÆ·µÄÃ÷ÊÓÒ°ºÍÓ«¹âÏÔÓ°µÄÏÔ΢½á¹¹£¬Í¬Ê±¿ÉÒÔÀûÓÃÓ« ¹âÏÔ΢¾µÅäÌ×µÄÉãÏñϵͳÅÄÕÕ¡£¸ù¾Ý¸÷×ÔµÄÐèÇ󣬿ÉÑ¡Ôñ20X¡¢40X¡¢60X¡¢100XÎï¾µ£¬Ê¹ ÓÃÓ;µÓë¾µÓÍЧ¹û¸ü¼Ñ¡£¹Û²ìºó£¬ÑùÆ·¿ÉÒÔÔÚ4¡ãCÏÂ±Ü¹â´æ·Å£¬»òÕß»ØÊÕÔØ²£Æ¬¡£Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇËùÓÃϸ°ûÅÀƬÊÇÄܹ» ʹϸ°û½ÏÀιÌÌù¸½ÓÚÆäÉϵĸDz£Æ¬£¬ºñ¶È0. 15-0. 22mm,Ê×ѡԲÐÎÇÒÖ±¾¶Îª1. 5-2. 2cm,·½ ÐÎÒà¿ÉʹÓÃÇÒ³¤¶ÈΪ1. 5-2. 2cm¡£Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇËùÊöµÄ(²½ÖèII. 2¡¢ II. 3,11. 4ÖÐ)ËÙЧƯϴ£¬¾ßÌå·½·¨ÊÇÓÃÄ÷×ӰѳÖÅÀƬ£¬¿ìËÙ¡¢ÉÏÏ·´¸´µØÊ¹ÅÀƬ½þ/³öPBS ¶à´Î(15-35´Î)£¬ÒÀ´ÎÔÚ3¸öÁ¿±­ÖнøÐÐÆ¯Ï´¡£Ï´ºóÈÃÅÀƬһ±ßµÄ±ßÔµ½Ó´¥Ö½½í£¬ÎüÈ¥ÅÀƬ ÉϵÄPBS¡£Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇËùÊöµÄÔÚ·â±Õ·õÓý¡¢Ò» ¿¹·õÓý¡¢¶þ¿¹·õÓýÖеķõÓý·½Ê½ÊǰÑÅÀƬÕýÃæÏòϸ²¸Ç·õÓýÈÜÒº¡£Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇËùÊöµÄ¿¹Ó«¹âË¥Í˼Á Å䷽ΪIOmg¶Ô±½¶þ°·ÈܽâÈëIml PBS,ÔÙÓë9ml¸ÊÓÍ»ìºÏ£¬ÅäÖÆ³Éº¬lmg/ml¶Ô±½¶þ°·ºÍ 90% (V/V)¸ÊÓ͵ÄÈÜÒº¡£ÊµÑé½á¹û˵Ã÷ʵÑé1 ¾Þϸ°û²¡¶¾(AD169Öê)¸ÐȾ³ÉÏËάϸ°û(5 X IO5ϸ°û/IOOmmÅàÑøÃó£¬15Ƭ¸Ç²£ Ƭ)£¬ÔÚ¸ÐȾºóMh-96h¼ä£¬ÔÚϸ°ûºËÄÚÐγɵã×´¸´ÖÆÖÐÐÄ¡¢Ð¡Ð͸´ÖÆÖÐÐÄ¡¢ÖÐÐ͸´ÖÆÖÐÐÄ£¬ ÒÔ¼°×îÖյĵ¥¸ö´óÐ͵¥¸´ÖÆÖÐÐÄ¡£(ͼ1A¡¢Í¼1B¡¢Í¼1C¡¢Í¼1D¡¢Í¼1E¡¢Í¼1F¡¢Í¼1G¡¢Í¼1H)ʵÑé2:
¾Þϸ°û²¡¶¾(TowneÖê)¸ÐȾ³ÉÏËάϸ°û1 ºó£¬ÒõÐÔ¶ÔÕÕϸ°û(IE-1ÒõÐÔµÄϸ °û)ÖÐÕý³£µÄ¼¡¶¯µ°°×Ë¿½á¹¹Óë·Ö²¼£»²¡¶¾¸ÐȾϸ°ûÖÐIE-IÑôÐÔ£¬¼¡¶¯µ°°×Ë¿½â¾Û²¢°éËæ ϸ°ûÐÎ̬¸Ä±ä¡£(ͼ2A¡¢Í¼2B¡¢Í¼2C¡¢Í¼2D¡¢Í¼2E¡¢Í¼2F)ʵʩÀýÖÐËùʵÑéÓõÄÖ÷Òª²ÄÁÏÈç ÏÂA.²ÄÁÏ¡¤Ï¸°ûÅÀƬ(Fisherbrand)£¬Ö±¾¶ 18mm£¬ºñ¶È 0. 2mm¡£¡¤±ê×¼ÔØ²£Æ¬(Fisherbrand)£¬ºñ¶È 1_¡£¡¤ÆäËü12¿×°å¡¢IOOmlËÜÁÏÁ¿±­3¸ö¡¢ÑÛ¿ÆÄ÷×Ó¡¢parafilm·â¿ÚĤ¡£B.ÊÔ¼Á¡¤ 10XPBS ºÌ¿Ú IX PBS¡£. 3% (M/V)¼×È©ÈÜÒºÓà 82ml ÕôÁóË®¡¢IOml 10XPBS¡¢8. 5ml 37% (M/V)¼×È©ÈÜ Òº(ºþ±±°ÂÉúвÄÁϿƼ¼ÓÐÏÞ¹«Ë¾)ÅäÖÆ³ÉIOOmlµÄÈÜÒº£¬4¡ãC´æ·Å¡£¡¤ 1% Triton-X-IOO ÈÜÒº½« Iml Triton-X-100 (¹º×ÔÜöÝÍÉúÎ﹫˾)ÈÜÈë 99ml PBS£¬Åä³É 100ml 1 % Triton-X-100 ÈÜÒº£¬ÊÒδæ·Å¡£ ÎÞѪÇå·â±ÕÒº¼´º¬ÓÐ1% (M/V)ţѪÇå°×µ°°×(BSA) (Biosciences PTY Ltd.) ºÍ0¡¤ 01 % (V/V)ÍÂÎÂ-20 (Tween-20)(¹º×Ô·Éôà¿Æ¼¼¹«Ë¾)µÄPBSÈÜÒº£¬4¡ãC´æ·Å¡£¡¤ 30% (V/V)̥ţѪÇå·â±ÕҺ̥ţѪÇå(º¼ÖÝËļ¾Çà)ÓëÎÞѪÇå·â±ÕÒº°´ÕÕ 3 7±ÈÀýÅäÖÆ£¬4¡ãC´æ·Å¡£¡¤¿¹Ó«¹âË¥Í˼Á10mg¶Ô±½¶þ°·(¹º×ÔÉϺ£É½ÆÖ»¯¹¤ÓÐÏÞ¹«Ë¾)ÈܽâÓÚIml PBS ÖУ¬ÔÙÓë9ml¸ÊÓÍ»ìºÏ¡£ÒÔIml/¹Ü·Ö×°£¬-80¡ãC³¤ÆÚ´¢´æ¡£³£ÓõÄÔò´¢´æÓÚ_20¡ãC¡£ ϸ°ûºËȾÁÏHoechst£¬l 5000Ï¡ÊÍʹÓᣡ¤¿¹Ìåa)±ê¼Ç¾Þϸ°û²¡¶¾¸´ÖÆÖÐÐĵĿ¹Ìå(ͼ1A¡¢Í¼IB¡¢Í¼1C¡¢Í¼ID)¡ª¿¹Îª¿¹UL44µÄ µ¥¿Ë¡¿¹Ìå(IgGl£¬¹º×ÔRumbaugh-Goodwin°©Ö¢Ñо¿Ëù£¬ÃÀ¹ú)£¬1 1000Ï¡ÊÍʹÓã»¶þ¿¹ ΪTRITCñîÁªµÄÑò¿¹ÊóIgGlµ¥¿Ë¡¿¹Ìå(Southern Biotech¹«Ë¾£¬ÃÀ¹ú)£¬1 250Ï¡ÊÍʹÓá£b)±ê¼Ç΢˿µ°°×µÄ¿¹Ìå(ͼ2B¡¢Í¼2E)¡ª¿¹ÎªÊó¿¹aCtin(pan Ab_5)µÄµ¥¿Ë¡ ¿¹Ìå(IgGl£¬¹º×Ô NeoMarkers£¬Frement£¬CA£¬USA)£¬1 100 Ï¡ÊÍʹÓã»¶þ¿¹Îª Alexa488 ñîÁª µÄÑò-¿¹ÊóIgGlµ¥¿Ë¡¿¹Ìå(¹º×ÔMolecular Probes£¬ÃÀ¹ú)£¬1 5000Ï¡ÊÍʹÓá£c)±ê¼ÇÈ˾Þϸ°û²¡¶¾IE-IµÄ¿¹Ìå(ͼ2C¡¢Í¼2F)¡ª¿¹Îª¿¹IE-IµÄµ¥¿Ë¡¿¹Ìå (IgGh£¬ÓÉÃÀ¹ú°¢À­°ÍÂí´óѧµÄBill Britt½ÌÊÚÔùËÍ)£¬1 25Ï¡ÊÍʹÓã»¶þ¿¹ÎªTRITCñî ÁªµÄÑò¿¹ÊóIgG^iµ¥¿Ë¡¿¹Ìå(¹º×ÔMolecularfrobes£¬ÃÀ¹ú)£¬1 250Ï¡ÊÍʹÓá£10
ȨÀûÒªÇó
1.Ò»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬Æä²½ÖèÊÇA.ϸ°ûÅàÑø²¢¹Ì¶¨ÓڸDz£Æ¬ÉÏ£¬ÖƱ¸Ï¸°ûÅÀƬ1)ϸ°ûÅÀƬµÄÖÆ±¸¹ý³ÌÊÇa ÔÚ½ÓÖÖϸ°ûǰ£¬ÏȽ«Ãð¾úºóµÄÅÀƬ·ÅÈëÅàÑøÃó£¬ÔÙ¼ÓÈëÅàÑø»ùºÍϸ°û£¬Ê¹Ï¸°û¾ù„òµØ Ìù¸½ÔÚÅÀƬÉϱíÃæºÍδ±»ÅÀƬ¸²¸ÇµÄÅàÑøÃóµ×²¿£¬´ýϸ°ûÌù±Úºó°´¸÷×ÔµÄʵÑ鼯»®ÅàÑøºÍ ´¦Àíϸ°û£¬ÔÚϸ°ûÌù¸½¼°Éú³¤¹ý³ÌÖв»ÒªÅÀƬÏà»¥ÖØµþ£¬ËùÓÃϸ°ûΪ³ÉÏËάϸ°û£¬ÅàÑø»ùΪ MEM £»b ½«º¬Óдý¼ì²âϸ°ûµÄÐüÒºµÎ¼ÓÔÚÅÀƬÉÏ£¬Ê¹Æä·ç¸É2)ÊÕ¼¯Ï¸°ûÅÀƬÓÃÄ÷×Ó½«Ï¸°ûÅàÑøÃóÖеÄÅÀƬȡ³ö£¬·ÅÈë12¿×°åÖУ¬ÅÀƬÕýÃæÏòÉÏ£»3)ƯϴÎü³ý12¿×°åÖеÄPBS£¬ÔٴμÓÈëPBS²¢Îü³ý£»4)ϸ°û¹Ì¶¨Ïòÿ¸ö¿×¼ÓÈëIml¹Ì¶¨¼Á3%M/V¼×È©ÈÜÒº£¬ÊÒηÅÖÃIOmin £»5)ƯϴÎü³ý¹Ì¶¨¼Á£¬ÓÃPBSÏ´2´Î£»6)ϸ°û´©Í¸Ã¿¿×¼ÓÈëIml´©Í¸¼Á£¬Triton-X-100£¬ÊÒηÅÖÃ5-lOmin£»7)ƯϴÎü³ý´©Í¸¼Á£¬ÓÃPBSÏ´£»B.ÃâÒßÓ«¹âȾɫ1)Ô¤±¸·â¿ÚĤºÍPBS;2)·â±ÕÅäÖÆ²¢µã¼Ó·â±ÕÒº£¬½«30¦Ì1̥ţѪÇåÓë70¦Ì 1µÄÎÞѪÇå·â±ÕÒº»ìºÏ£¬ÅÀƬµÄ ƯϴÓëÕã¸É£¬¼ÐסÅÀƬ£¬Ê¹ÅÀƬ½þ/³öPBS½øÐÐÆ¯Ï´£¬È»ºó°ÑÅÀƬµÄÒ»±ß·ÅÖ½½íÉÏÎüÈ¥¶àÓà PBS£¬ÅÀƬ¸ÇÓÚ·â±ÕÒºÉÏ£¬ÊÒηõÓý15min £»ÖÕÖ¹·â±Õ£¬ÓÃ1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ ÈëPBS£¬ÅÀƬ¸¡Æð£¬Æ¯Ï´ÓëÕã¸É£»3)Ò»¿¹·õÓýÅäÖÆÒ»¿¹ÈÜÒº£¬ÅÀƬ¸ÇÓÚÒ»¿¹ÈÜÒºÉÏ£¬ÊÒηõÓýIOmin £»ÖÕÖ¹Ò»¿¹·õÓý£¬Óà 1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬ÅÀƬ¸¡Æð£¬Æ¯Ï´ÓëÕã¸É£»4)¶þ¿¹·õÓýÅäÖÆ¶þ¿¹ÈÜÒº£¬ÅÀƬ¸ÇÓÚ¶þ¿¹ÈÜÒºÉÏ£¬ÊÒηõÓýIOmin £»ÖÕÖ¹¶þ¿¹·õÓý£¬Óà 1000 ¦Ì 1µÄÒÆÒºÇ¹ÏòÅÀƬµÄ±ßÔµ×¢ÈëPBS£¬ÅÀƬ¸¡Æð£¬Æ¯Ï´ÓëÕã¸É£»5)×°ÔØÅÀƬ׼±¸ÅÀƬ£¬µã¼Ó¿¹Ó«¹âË¥Í˼Á£¬Çå½àÅÀƬ£¬½«ÅÀƬ¸ÇÓÚÔØ²£Æ¬ÉϵĿ¹Ó«¹â Ë¥Í˼ÁÉÏ£¬ÓÃÄ÷×ÓÇáѹÅÀƬÌù½ôÔØ²£Æ¬£»ÓÃÎü³ýÅÀƬÖÜΧ¶àÓàµÄ¿¹Ó«¹âË¥Í˼Á£¬ÔÚÅÀƬ±ßÔµ µãÉÏÖ¸¼×Ó͹̶¨£¬¹Û²ì»ò±£´æÑùÆ·£»C.Ó«¹âÏÔ΢¾µÏ¹۲ìÓ«¹â¼°ÅÄÕÕ¡£
2.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇ ËùÊöµÄϸ°ûÅÀƬÊÇÌù¸½ÓÚÆäÉϵĸDz£Æ¬£¬ºñ¶È0. 15-0. 22mm,Ö±¾¶Îª1. 5-2. 2cm,³¤¶ÈΪ 1. 5-2. 2cm¡£
3.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇ ËùÊöµÄ¿¹Ó«¹âË¥Í˼ÁΪIOmg¶Ô±½¶þ°·ÈܽâÈëIml PBS,ÔÙÓë9ml¸ÊÓÍ»ìºÏ£¬ÅäÖÆ³Éº¬Img/ ml¶Ô±½¶þ°·ºÍ90% V/V¸ÊÓ͵ÄÈÜÒº¡£
4.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇ ËùÊöµÄ¹Ì¶¨¼ÁΪ¼×È©¡¢¶à¾Û¼×È©¡¢¼×´¼¡¢Îì¶þÈ©¡¢±ûͪÈÜÒºÖеÄÈÎÒâÒ»ÖÖ¡£
5.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬ÆäÌØÕ÷ÊÇ ËùÊöµÄ´©Í¸¼ÁΪNP-40¡¢Ôí½ÇÜÕ¡¢ÍÁΡ¢Ñ󵨻ÆÔíÜÕÖеÄÈÎÒâÒ»ÖÖ¡£
È«ÎÄÕªÒª
±¾·¢Ã÷¹«¿ªÁËÒ»ÖÖ»ùÓÚϸ°ûÅÀƬµÄ¿ìËÙ¾­¼ÃµÄÃâÒßÓ«¹â·½·¨£¬Æä²½ÖèÊÇA.ϸ°ûÅàÑø²¢¹Ì¶¨ÓڸDz£Æ¬ÉÏ£¬ÖƱ¸Ï¸°ûÅÀƬaÔÚ½ÓÖÖϸ°ûǰ£¬ÏȽ«Ãð¾úºóµÄÅÀƬ·ÅÈëÅàÑøÃó£¬ÔÙ¼ÓÈëÅàÑø»ùºÍϸ°û£»b½«º¬Óдý¼ì²âϸ°ûµÄÐüÒºµÎ¼ÓÔÚÅÀƬÉÏ£¬Ê¹Æä·ç¸É£»ÊÕ¼¯Ï¸°ûÅÀƬ£»Æ¯Ï´£»Ï¸°û¹Ì¶¨£»Æ¯Ï´£»Ï¸°û´©Í¸£»Æ¯Ï´Îü³ý´©Í¸¼Á£»B.ÃâÒßÓ«¹âȾɫԤ±¸·â¿ÚĤºÍPBS£»·â±Õ£»Ò»¿¹·õÓý£»¶þ¿¹·õÓý£»×°ÔØÅÀƬ£»C.Ó«¹âÏÔ΢¾µÏ¹۲ìÓ«¹â¼°ÅÄÕÕ¡£¼ò±ãÒ×ÐС£²Ù×÷¼ò±ã£¬ÈÝÒ×ÕÆÎÕ£¬ËùÓвÙ×÷ÔÚÊÒÎÂϽøÐС£´ïµ½Ê¡Ê±¼ä¡¢Ê¡¹óÖØÊÔ¼Á£¬ÖÊÁ¿/Ч¹ûºÃ¡£ÄÜ׼ȷµØ¶¨Î»¿¹Ô­µÄλÖúÍÏÔʾÏà¶ÔÁ¿£¬Ëù±ê¼Ç°Ð·Ö×ÓµÄÓ«¹âÇåÎú¶ø±³¾°Ó«¹âºÜµÍ¡£
Îĵµ±àºÅG01N33/543GK102043047SQ20101052901
¹«¿ªÈÕ2011Äê5ÔÂ4ÈÕ ÉêÇëÈÕÆÚ2010Äê11ÔÂ2ÈÕ ÓÅÏÈȨÈÕ2010Äê11ÔÂ2ÈÕ
·¢Ã÷ÕßÒÁÀöɯ°×¸£¶ûͼÄÇÍÐ, ¶ÎÓ¨ÁÁ, ÂÞÃô»ª ÉêÇëÈË:Öйú¿ÆÑ§ÔºÎ人²¡¶¾Ñо¿Ëù

  • רÀûÃû³Æ£º¿ìËÙ¼ì²âÓлúÁ׺Ͱ±»ù¼×Ëáõ¥Ààɱ³æ¼ÁµÄ×éºÏÎï¼°¼ì²â·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°×éºÏÎï£¬ÌØ±ðÉæ¼°Ò»ÖÖ¿ìËÙ¼ì²âÓлúÁ׺Ͱ±»ù¼×Ëáõ¥Ààɱ³æ¼ÁµÄ×éºÏÎï¼°¼ì²â·½·¨¡£ÓлúÁ׺Ͱ±»ù¼×Ëáõ¥Ààɱ³æ¼Áɱ³æ¼ÁÊǵڶþ´ÎÊÀ½ç´óÕ½ºó¿ªÊ¼·¢Õ¹ÆðÀ´µÄ£¬²¢ÊÇ·¢Õ¹ËÙ¶È×î¿ìµÄ
  • רÀûÃû³Æ£ºÒ»ÖÖתËÙ²âÁ¿×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÊôÓÚÖÇÄÜ»¯¿ØÖÆÁìÓò£¬¾ßÌåÉæ¼°Ò»ÖÖתËÙ²âÁ¿×°Öᣠ±³¾°¼¼Êõ£º²â¿Ø¼¼ÊõÔÚתËÙ²âÁ¿·½ÃæµÄ´óÁ¿Ó¦Óã¬Ê¹»ñµÃµÄÏà¹Ø¿ØÖÆÐÅÏ¢¸ü¼Ó¿ì½ÝÓë׼ȷ¡£ ÏÖÖ÷ҪʹÓõÄתËÙ²âÁ¿×°ÖÃÖ÷ÒªÓÐÀëÐÄʽתËÙ²âÁ¿×°ÖúʹÅÐÔ
  • רÀûÃû³Æ£ºÑªºìµ°°×¿ìËÙ¼ì²âÆ¿µÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°Ò»ÖֿɲâÊÔÎÞ³¥Ï×ѪÈËԱѪҺÖÐѪºìµ°°×º¬Á¿µÄ×°Öã¬ÓÈÆäÊÇ¿ÉÅжÏÎÞ³¥Ï×ѪÈËÔ±ÊÇ·ñ´æÔÚÆ¶ÑªµÄѪºìµ°°×¿ìËÙ¼ì²âÆ¿¡£±³¾°¼¼Êõ£º ÏÖ½ñѪºìµ°°×º¬Á¿µÄ²â¶¨Ó¦Ó÷dz£¹ã·º£¬Èçɸ²é¹©ÑªÕ߯¶Ñª¡¢²úǰ¼ì²é¼°
  • רÀûÃû³Æ£ºÒ»ÖÖÆû³µµÄй©ÒǵÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÊôÓÚ¼ì²â¼¼ÊõÁìÓò£¬ÌرðÊÇÒ»ÖÖÆû³µµÄй©ÒÇ¡£ ±³¾°¼¼Êõ£ºÆû³µÈç´æÔÚÆøÃÜÐÔÄܲ³µÁ¾ÍùÍùÊÇ·ÅÒ»¸öÍíÉϾÍÕû³µÈ±Æø£¬¶ø³¤Ê±¼ä³äÆø»áºÄ ·Ñ´óÁ¿È¼ÁÏ¡£Í¼1ÊÇÏÖÓÐʹÓÃµÄÆøÃÜÐÔ¼ì²âÉ豸½á¹¹Ê¾Òâͼ£¬ËüÖÁ
  • רÀûÃû³Æ£º£º¿Éµ÷À©Õ¹¹âÔ´ÕÕÃ÷µÄͬÖáì³Ë÷ÐÍͬ²½ÒÆÏà¸ÉÉæÒǵÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º£º±¾·¢Ã÷ÊôÓÚ¹âѧ¸ÉÉæ²âÁ¿ÒÇÆ÷£¬ÓÈÆäÉæ¼°ì³Ë÷ÐÍͬ²½ÒÆÏà¸ÉÉæÒÇ¡£±³¾°¼¼Êõ£º£ºì³Ë÷Ð͸ÉÉæÒDzÉÓñ»²â¹âÊøÓë²Î¿¼¹âÊøµÄ¹²¹â·Éè¼Æ£¬³ý²Î¿¼ÃæÍ⣬¸ÉÉæÒǹâѧϵͳ×ÔÉíµÄÏñ²î¶Ô±»²â¹âÊø
  • רÀûÃû³Æ£ºÒ»ÖÖÊý×ÖʽÖÐ¸ßÆµµ¼ÏßµçÁ÷¼ì²âÄ£¿éµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÊôÓÚ¹¤Òµ²âÁ¿¿ØÖÆÁìÓò£¬É漰СÐźŲɼ¯¡¢µç´ÅÆÁ±Î¼¼Êõ£¬ÌرðÉæ¼°Ò»ÖÖÊý×ÖʽÖÐ¸ßÆµµ¼ÏßµçÁ÷¼ì²âÄ£¿é¡£±³¾°¼¼Êõ£º¹¤ÒµÎÐÁ÷¼ÓÈÈÉ豸»òÕߴŸÐÓ¦ÈÈÁƵÈÉ豸ÓÉÓÚÐèÒª¶Ô¸ÐÓ¦ÏßÈ¦ÔØÁ÷½øÐÐʵ
ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
È«¹ú·þÎñÈÈÏߣº13062023238
µç»°£º13062023238
µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
¹«Ë¾¶þάÂë
Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿